Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Dare Bioscience, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −1 vs. Q4 2025
- Shares held
- 1.02M
- +561.6K (+121.2%) vs. Q4 2025
- Total value
- $1.87M
- +$972.3K (+108.8%) vs. Q4 2025
- New holders
- 7
- 6 more added
- Sold out
- 8
- 3 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DARE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $2.75M |
| Q1 2026 | 25 | $1.87M |
| Q4 2025 | 27 | $1.90M |
| Q3 2025 | 21 | $2.12M |
| Q2 2025 | 23 | $2.16M |
| Q1 2025 | 24 | $2.39M |
| Q4 2024 | 25 | $2.43M |
| Q3 2024 | 22 | $2.08M |
| Q2 2024 | 28 | $2.46M |
| Q1 2024 | 36 | $3.35M |
| Q4 2023 | 35 | $2.04M |
| Q3 2023 | 30 | $5.97M |
| Q2 2023 | 28 | $5.92M |
| Q1 2023 | 29 | $7.16M |
| Q4 2022 | 30 | $5.82M |
| Q3 2022 | 31 | $7.56M |
| Q2 2022 | 36 | $9.12M |
| Q1 2022 | 40 | $9.89M |
| Q4 2021 | 38 | $13.7M |
| Q3 2021 | 37 | $8.07M |
| Q2 2021 | 34 | $6.40M |
| Q1 2021 | 30 | $6.10M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Dare Bioscience, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 462,305 | $841.4K | 0.00% | +462,305 | New |
| Geode Capital Management, LLC | 177,839 | $323.7K | 0.00% | +59,184+49.9% | Added |
| US Bancorp | 91,370 | $166.3K | 0.00% | +70,450+336.8% | Added |
| Vanguard Fiduciary Trust Co | 65,938 | $120.0K | 0.00% | +65,938 | New |
| UBS Group AG | 43,363 | $78.9K | 0.00% | +22,448+107.3% | Added |
| State Street Corp | 23,515 | $42.8K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 22,339 | $40.7K | 0.00% | +11,356+103.4% | Added |
| Susquehanna International Group, LLP | 17,130 | $31.2K | 0.00% | −52,891−75.5% | Reduced |
| BlackRock, Inc. | 16,971 | $30.9K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 15,431 | $28.1K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 15,334 | $27.9K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 14,639 | $26.6K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 13,279 | $24.2K | 0.00% | −19,757−59.8% | Reduced |
| Objectivity Squared, LLC | 10,915 | $19.9K | 0.01% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 10,222 | $19.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 10,195 | $18.6K | 0.00% | −9,100−47.2% | Reduced |
| Farther Finance Advisors, LLC | 9,325 | $17.7K | 0.00% | +9,325 | New |
| Vanguard Global Advisers, LLC | 2,940 | $5.35K | 0.00% | +2,940 | New |
| Insight Financial Services | 950 | $1.73K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 645 | $1.17K | 0.00% | +70+12.2% | Added |
| Mather Group, LLC. | 85 | $155 | 0.00% | +85 | New |
| Caldwell Sutter Capital, Inc. | 17 | $31 | 0.00% | 00.0% | Unchanged |
| CWM Advisors, LLC | 14 | $26 | 0.00% | +2+16.7% | Added |
| Caitong International Asset Management Co., Ltd | 2 | $4 | 0.00% | +2 | New |
| Royal Bank of Canada | 59 | $0 | 0.00% | +59 | New |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,200−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −17,900−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,559−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,497−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −2,405−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −129−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |